Delta Sleep-Inducing Peptide · Protocol Guide
DSIP: The Honest Sleep-Architecture Peptide Guide
DSIP is the most studied sleep peptide and the most misunderstood. It is not a sedative. The clinical trials are mostly from 1981 to 1985. The community uses it anyway. This guide is direct about what is known and what is not.
FDA Status
Off-Label, 503A Compounded
Pharmacy
Optimal Balance Pharmacy (503A licensed)
Medical Service
RxPepsDirect, physician-supervised
Access
33 U.S. States
Our promise: DSIP cannot force sleep, will not make you drowsy, and most clinical data is from intravenous infusion studies that bear limited resemblance to consumer subcutaneous use. We say so.
Medically reviewed by Dr. Jonathan Snipes, MD. Last reviewed May 18, 2026.Section 01
What DSIP Actually Is
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from rabbit brain tissue in 1977. It is produced in the hypothalamus and present in low concentrations in human plasma, rising in the late afternoon and evening. Its name reflects the original finding: infusing it into the third ventricle of experimental animals induced delta-wave (slow-wave) sleep patterns.
What separates DSIP from conventional sleep aids is its proposed mechanism. DSIP does not suppress the central nervous system or bind GABA receptors the way benzodiazepines or z-drugs do. It is thought to act as a sleep-architecture modulator, potentially deepening slow-wave sleep without inducing sedation. The community of consumers now experimenting with it is doing so with a compound whose clinical development was effectively abandoned in the late 1980s for funding reasons, not because it was proven ineffective.
1977
Year of discovery. Most human trials completed before 1986.
<15 min
In-vivo half-life due to aminopeptidase degradation
97%
Withdrawal symptom improvement in a 1984 opiate study (n=27)
Section 02
Who It Is Actually For
| Profile | Primary Goal | Fit |
|---|---|---|
| Treatment-Resistant Insomnia | Sleep architecture restoration after failed first-line therapies | Best Fit |
| Chronic Pain with Sleep Disruption | Combined pain-modulation and slow-wave sleep restoration | Strong Fit |
| Addiction Recovery (Adjunct) | Withdrawal symptom reduction, autonomic stabilization | Adjunct Use |
| Longevity Biohacker | Antioxidant and sleep-quality support | Speculative |
| Sleep-Onset Insomnia Only | Falling asleep faster | Poor Fit |
Profile
Primary Goal
Fit
Profile
Primary Goal
Fit
Profile
Primary Goal
Fit
Profile
Primary Goal
Fit
Profile
Primary Goal
Fit
Section 03
How It Works
DSIP interacts with multiple neurobiological systems: sleep-wake regulation, the HPA (hypothalamic-pituitary- adrenal) axis, growth hormone secretion, pain modulation, and possibly opiate receptor pathways. This broad profile is why DSIP has attracted interest across several niches. It is also why it remains difficult to characterize.
Section 04
Realistic Expectations
DSIP does not work like Ambien. You will not feel sedated within minutes. The reported effects accumulate over a protocol of nightly use and the strongest signal is improved sleep depth, not sleep onset.
Subtle Architecture Shift
Some users report deeper sleep, fewer nighttime wakings, and more vivid dreams. Many notice nothing at this stage. No sleep-onset effect should be expected.
Accumulated Signal
If DSIP is working for you, improved morning refreshment and reduced sleep fragmentation become more apparent. Sleep tracking devices may show increased slow-wave sleep percentage.
Full Protocol Assessment
The earliest point to evaluate whether the protocol is producing meaningful change. If no improvement, your RxPepsDirect physician will discuss alternatives.
Section 05
Dosing Protocol
| Context | Dose | Timing | Evidence Basis |
|---|---|---|---|
| RxPepsDirect Standard | 0.1 to 0.3 mg (5 to 15 units) | 30 to 60 minutes before bed, subcutaneous | Community + Historical |
| Higher-Dose Sleep Protocol | 0.3 to 0.5 mg | Bedtime, subcutaneous | Community Anecdote |
| Original IV Clinical Dose (1980s) | 25 to 60 nmol per kg | IV infusion (not consumer-applicable) | Historical Human Data |
Context
Dose
Timing
Evidence Basis
Context
Dose
Timing
Evidence Basis
Context
Dose
Timing
Evidence Basis
Subcutaneous injection into abdominal fat. Standard insulin syringe (28 to 31 gauge, 6 to 8 mm needle). Timing matters: inject 30 to 60 minutes before bed for the slow-wave architecture effect to align with the natural deepest-sleep window.
Section 06
Ready to Inject
0
Reconstitution steps required
503A
Licensed pharmacy (Optimal Balance), physician-supervised
Overnight
FedEx shipping in a reusable cooled travel case
Section 07
Stacking
Pairs Well With
Sermorelin
GH secretion happens during slow-wave sleep. DSIP's architecture effect may compound GHRH-analog efficacy.
Magnesium glycinate (oral)
Different mechanism (GABA-A modulation, muscle relaxation). Commonly stacked for sleep.
L-theanine (oral)
Alpha-wave inducer. Complementary mechanism, no peptide interaction.
Sleep hygiene baseline
DSIP is not a substitute for dark room, cool temperature, consistent schedule. It enhances good sleep architecture, it does not create it.
Approach With Caution
Benzodiazepines / Z-drugs
Different mechanism but both affect sleep architecture. Discuss with your physician before combining.
Alcohol within 4 hours of bed
Disrupts slow-wave sleep. Negates DSIP's primary mechanism.
Pregnancy / lactation
No safety data. Avoid.
Severe sleep apnea (untreated)
DSIP does not address obstructive apnea. Treat the underlying condition first.
Section 08
Pricing
Who You Pay, and What For
Pharmacy: Medication
$80 per 10 mg vial. Compounded and shipped by Optimal Balance Pharmacy, a 503A licensed compounding pharmacy.
Medical Service: Physician Consultation
$39 medical visit fee. Intake consultation including sleep-history screening, protocol design, prescription writing, and follow-up. Billed by RxPepsDirect.
Section 09
Legal Access in 33 States
503A Licensed Pharmacy
Optimal Balance Pharmacy, U.S. licensed
Physician Prescription Required
Compounded medication, Rx only
Off-Label, Legal Practice
Standard and legal in U.S. medicine
Not Controlled, Not Scheduled
No DEA classification
Section 10
Community Q&A
Will DSIP make me fall asleep faster?
Probably not. DSIP is not a sedative. If your primary problem is sleep onset, melatonin, sleep hygiene, or CBT-I are more reliable first-line interventions.
When should I inject?
30 to 60 minutes before bed. The half-life is short but the architecture effect is theorized to align with the early-night slow-wave sleep window.
Why is DSIP not FDA-approved?
Clinical development was abandoned in the late 1980s due to academic funding gaps and mixed-quality trial design rather than safety or proven ineffectiveness. The 15-minute half-life made commercial development unattractive.
What about the 1984 opiate withdrawal study?
Encouraging but small (n=27), old, and used IV infusion. RxPepsDirect physicians may consider DSIP as an adjunct in addiction recovery, but it is not a first-line tool and requires careful integration with the broader treatment plan.
What if Optimal Balance is out of stock?
Your RxPepsDirect physician will be notified and you will be contacted before any delay impacts your protocol. You only pay the pharmacy when your prescription actually ships.
Section 11
The RxPepsDirect Model
Pharmacy: Optimal Balance, 503A Licensed
Optimal Balance Pharmacy compounds your DSIP under a patient-specific prescription, USP <797> sterile standards, and federal 503A oversight.
Medical Service: RxPepsDirect Physicians
A licensed physician reviews your sleep history, screens for sleep apnea and other conditions DSIP does not address, and designs your protocol.
Transparent Safety Communication
The guide flags the non-sedative mechanism, the 15-minute half-life problem, the 40 to 50 percent non-responder rate, and the abandonment of clinical development. We do not hide limitations.
Legal Access in 33 States
Every shipment is a compounded prescription medication filled by a 503A licensed pharmacy under a physician prescription.
References
- Schneider-Helmert D, Schoenenberger GA. Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep. Neuropsychobiology. 1983. PMID: 6353350
- Schoenenberger GA. Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP). Eur Neurol. 1984. PMID: 6499794
- Dick P, Costa C, Fayolle K, et al. DSIP in the treatment of withdrawal symptoms from alcohol and opiates. Eur Neurol. 1984. PMID: 6499820
Related protocol guides
Other protocols in the same clinical territory. Each guide is co-bylined by a licensed RxPepsDirect prescriber.
TP-7 tuftsin analog (anxiolytic)
Selank protocol guide: tuftsin-analog anxiolytic, Russian RCT evidence, and the 14-day course
Russian clinical use for generalized anxiety. Non-sedating, no documented tolerance. Western replication is thin. RxPepsDirect prescribes the Semax/Selank combo spray.
Pair-bonding nonapeptide hormone
Oxytocin protocol guide: bonding peptide biology, troche vs nasal, and the context-dependent effect
FDA-approved as Pitocin since 1953 for obstetric use. Off-label sublingual and intranasal for bonding and anxiety. Pregnancy is a hard contraindication.
Continue reading